Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

203.98

+2.76 (1.37%)

At close: Apr 28, 2026, 4:00 PM EDT

188.98

-15.00 (-7.35%)

After-hours: Apr 28, 2026, 7:59 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Total Neuroscience Revenue	2.88B	2.70B
Total Neuroscience Revenue Growth	6.68%	-0.35%
Total Oncology Revenue	1.13B	1.11B
Total Oncology Revenue Growth	1.60%	9.47%
Other Product Revenue	14.17M	11.47M
Other Product Revenue Growth	23.55%	-17.15%
Total Product Revenue, Net	4.02B	3.82B
Total Product Revenue, Net Growth	5.25%	2.25%
High-Sodium Oxybate AG Royalty Revenue	211.73M	217.58M
High-Sodium Oxybate AG Royalty Revenue Growth	-2.69%	186.59%
Other Royalty and Contract Revenue	34.01M	30.21M
Other Royalty and Contract Revenue Growth	12.58%	41.55%
Total Royalties and Contract Revenue	245.74M	247.79M
Total Royalties and Contract Revenue Growth	-0.83%	154.76%
Revenue (Other)	3.00K	4.00K
Revenue (Total)	4.27B	4.07B
Revenue (Total) Growth	4.88%	6.12%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	3.83B	3.66B
United States Revenue Growth	4.69%	4.88%
Europe Revenue	341.12M	312.71M
Europe Revenue Growth	9.09%	16.14%
All Other Countries Revenue	94.87M	96.14M
All Other Countries Revenue Growth	-1.32%	28.21%
Revenue (Other)	2.00K	-1.00K
Revenue (Total)	4.27B	4.07B
Revenue (Total) Growth	4.88%	6.12%

Updated Feb 24, 2026. Data Source: Fiscal.ai.